Zydus Lifesciences share price today, March 13: The share price of Zydus Lifesciences has cracked 2.6% in the last five days. (Image: Freepik) Nuvama Institutional Equities slashed the target ...
Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...
The board of directors of Ahmedabad-based Zydus Lifesciences on Tuesday approved the acquisition of a controlling 85.6 per cent stake in France-based orthopaedic technology firm Amplitude Surgical SA ...
Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...
Global MedTech Market attracts Zydus Interest; Company acquires French Device Maker for $326 million
New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...
Zydus Lifesciences Ltd. on Tuesday, March 11, said its board of directors approved the acquisition of 85.6% equity shares of Amplitude Surgical SA, France. In an exchange filing, the company said the ...
(Reuters) -India’s Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France’s Amplitude Surgical for 256.8 million euros (nearly $280 million) as part of its plans to expand further ...
Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for 256.8 million euros (nearly $280 million). The company ...
Ahmedabad: Zydus Lifesciences Limited, a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase from PAI Partners and Amplitude Surgical's management, as ...
Zydus Lifesciences has entered into exclusive negotiations to acquire a controlling 85.6 percent stake in France-based Amplitude Surgical SA, a leading medical technology company specialising in ...
Zydus Lifesciences on Monday said it has received approval from US health regulator USFDA to market a generic antifungal medication to treat dandruff, fungal infections, and other skin conditions. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results